These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5006547)

  • 1. [Some viewpoints on the rehabilitation of Parkinson syndrome with special reference to etiological factors].
    Appeltshauser D; Hennicke H
    Z Arztl Fortbild (Jena); 1971 Apr; 65(8):447-50. PubMed ID: 5006547
    [No Abstract]   [Full Text] [Related]  

  • 2. [Social problems and rehabilitation of the Parkinson patient].
    Klingler D; Trägner H
    Wien Med Wochenschr; 1986 Aug; 136(15-16):399-401. PubMed ID: 3788192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Parkinson disease and neurologic rehabilitation].
    Auff E; Fertl E; Schnider P
    Wien Med Wochenschr; 1995; 145(13):302-5. PubMed ID: 7571656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Parkinson's disease on the advance].
    Ceballos-Baumann A
    MMW Fortschr Med; 2009 Mar; 151(13):61-4. PubMed ID: 19504822
    [No Abstract]   [Full Text] [Related]  

  • 5. [Idiopathic Parkinson syndrome--current therapy].
    Ludin HP
    Ther Umsch; 1993 Nov; 50(11):771-4. PubMed ID: 8191382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The use of "controlled motor synergies" for rehabilitation of walking skills in parkinsonism].
    Rudnev VA; Prokopenko SV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(10):26-8. PubMed ID: 11712264
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of L-DOPA on spatiotemporal contrast sensitivity in Parkinson's disease.
    Mestre DR; Blin O; van den Brand CL; Azulay JP; Serratrice G
    Adv Neurol; 1996; 69():503-11. PubMed ID: 8615172
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy of parkinsonism].
    Hennicke H
    Psychiatr Neurol Med Psychol Beih; 1966; 4-5():115-20. PubMed ID: 5006301
    [No Abstract]   [Full Text] [Related]  

  • 9. A case of hedonistic homeostatic dysregulation.
    Kessel BL
    Age Ageing; 2006 Sep; 35(5):540-1. PubMed ID: 16799178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic effectiveness of modern antiparkinson agents].
    Kurako IuL; Volianskiĭ VE; Fadeev SM
    Vrach Delo; 1981 Feb; (2):7-11. PubMed ID: 7222616
    [No Abstract]   [Full Text] [Related]  

  • 11. Reversible lateral trunk flexion treated with a rehabilitation program in a patient with Parkinson's disease.
    Kataoka H; Ikeda M; Horikawa H; Ueno S
    Parkinsonism Relat Disord; 2013 Apr; 19(4):494-7. PubMed ID: 23274084
    [No Abstract]   [Full Text] [Related]  

  • 12. Global Mobility Task: index for evaluating motor impairment and motor rehabilitation programs in Parkinson's disease patients.
    Peppe A; Ranaldi A; Chiavalon C; Gasbarra A; Collepardo A; Romeo R; Pasqualetti P; Caltagirone C
    Acta Neurol Scand; 2007 Sep; 116(3):182-9. PubMed ID: 17714332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [If I were to wake-up clumsy and trembling...(or how to begin treatment of Parkinson disease].
    Linazasoro G
    Neurologia; 1998; 13(6):265-70. PubMed ID: 9734197
    [No Abstract]   [Full Text] [Related]  

  • 14. [Psychosis due to the interaction of erythromycin and bromocriptine in Parkinson disease].
    Alegre M; Noé E; Martínez Lage JM
    Neurologia; 1997 Nov; 12(9):429. PubMed ID: 9471184
    [No Abstract]   [Full Text] [Related]  

  • 15. [Electromyography parameters of muscular fatigue and recovery in patients with Parkinson's disease before and on medication].
    Antonen EG; Meĭgal AIu; Lupandin IuV
    Fiziol Cheloveka; 2005; 31(4):81-7. PubMed ID: 16122039
    [No Abstract]   [Full Text] [Related]  

  • 16. Managing pathological gambling in Parkinson's disease with enteral levodopa/carbidopa infusions.
    Gerschlager W; Bloem BR
    Mov Disord; 2009 Sep; 24(12):1858-60. PubMed ID: 19514056
    [No Abstract]   [Full Text] [Related]  

  • 17. Internet gambling and other pathological gambling in Parkinson's disease: a case series.
    Wong SH; Cowen Z; Allen EA; Newman PK
    Mov Disord; 2007 Mar; 22(4):591-3. PubMed ID: 17266073
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of apomorphine in clinical practice.
    MacMahon DG
    Adv Neurol; 1999; 80():529-33. PubMed ID: 10410767
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mechanism of the development of akinesia in Parkinson's disease --with reference to L-threo-DOPS therapy].
    Narabayashi H
    No To Shinkei; 1983 Nov; 35(11):1057-63. PubMed ID: 6362685
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of methamidoline in the treatment of parkinson-like manifestations due to neuroleptics].
    Arnone A; Parodi A
    Riv Sper Freniatr Med Leg Alien Ment; 1971 Dec; 95(6):1126-42. PubMed ID: 5143724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.